Condiciones de salud que mirobálano bellérico puede ayudar a apoyar.
T. bellirica fruit extract has been extensively characterized for antioxidant activity across multiple in vitro assays (DPPH, ABTS, FRAP), with an EC50 DPPH radical scavenging value of 7.2 ± 1.2 μg/mL. The fruit's rich polyphenol profile—gallic acid, ellagic acid, chebulagic acid, tannins—drives potent free radical scavenging. A comparative study found Bibhitaki scored highest among Triphala components for hydrogen peroxide radical scavenging.
A pharmacological mechanism study (Gilani et al., J Ethnopharmacol 2008) demonstrated that T. bellirica fruit exerts bronchodilatory effects via anticholinergic and calcium channel antagonist mechanisms, directly validating its traditional use in asthma. The fruit is listed for asthma in traditional Ayurvedic, Unani, Siddha, and Chinese medicine systems. Its antispasmodic properties on airway smooth muscle provide a credible mechanistic basis.
Animal and in vitro studies document that belleric myrobalan extracts and its constituent gallic acid exhibit hypoglycemic effects, including stimulation of insulin secretion, inhibition of starch digestion, and reduction of protein glycation. Preclinical data from diabetic rodent models show reductions in plasma glucose and improved glucose tolerance. No robust human RCT focused solely on T. bellirica for glycemic control has been published, but the preclinical evidence is substantial.
Animal studies demonstrate that T. bellirica extract reduces total cholesterol and LDL while increasing HDL in multiple hyperlipidemia models. In vitro, TBE inhibits LDL oxidation—a key step in atherogenesis. Gallic acid from the fruit also significantly reduces total cholesterol and LDL in animal studies. Traditional Ayurvedic use of Triphala (containing T. bellirica) for cholesterol management is documented. No robust human RCT on T. bellirica alone for cholesterol has been published.
In vitro and animal studies demonstrate that T. bellirica extracts suppress key pro-inflammatory mediators, including TNF-α, IL-1β, and reactive oxygen species. The fruit's polyphenols (gallic acid, ellagic acid, tannins) inhibit 15-lipoxygenase and macrophage inflammatory responses. This body of preclinical evidence is well-documented across multiple studies, though human RCT data specifically targeting chronic inflammation are sparse.
Belleric myrobalan has documented antidiarrheal properties supported by preclinical mechanistic studies and in vitro antimicrobial data against gastrointestinal pathogens. The fruit's tannins exert astringent action on the intestinal mucosa, and its anticholinergic and calcium antagonist effects (demonstrated in pharmacological studies) reduce intestinal hypermotility. Traditional use across Ayurveda, Unani, and traditional Chinese medicine for diarrhea is extensive.
Multiple preclinical studies—both in vitro (human follicle dermal papilla cells) and in vivo (mouse models of androgenetic alopecia)—demonstrate that T. bellirica extracts counter testosterone-induced hair growth regression, inhibit type II 5α-reductase (rate comparable to finasteride), and activate MAPK signaling pathways to remodel the follicular microenvironment. Seed oil use as a hair tonic is additionally documented in classical Ayurvedic texts.
Animal studies show T. bellirica extract protects against drug-induced cardiotoxicity, reduces CK-MB levels, restores cardiac antioxidant status, and improves lipid profiles (reducing cholesterol and triglycerides while increasing HDL). In vitro evidence demonstrates inhibition of LDL oxidation and macrophage-driven atherogenic inflammation. Traditional Ayurvedic use in Triphala includes prevention of heart tissue death. Human clinical evidence is lacking.
A randomized, double-blind, positive-controlled clinical trial (BMC Complement Med Ther 2020) demonstrated that aqueous T. bellirica extract (500–1000 mg twice daily, 24 weeks) significantly reduced serum uric acid and creatinine while improving eGFR in chronic kidney disease patients with hyperuricemia. An earlier clinical study also confirmed uric acid reduction. The extract's xanthine oxidase inhibitory activity is the proposed mechanism.
Multiple preclinical studies demonstrate that T. bellirica extracts and its constituent ellagic acid exert hepatoprotective effects, reducing liver enzyme markers and oxidative stress in drug-induced hepatotoxicity models in rodents. Effects are comparable to silymarin as a reference hepatoprotective standard. Traditional use for liver protection is documented across Ayurveda, Tibetan, and traditional Chinese medicine systems.
Animal studies demonstrate that T. bellirica extract reduces serum triglycerides in multiple models including diet-induced and drug-induced hyperlipidemia in rodents. In type 2 diabetic mice, hot-water fruit extract suppressed the rise of triglyceride levels and reduced liver triglyceride content. Gallic acid, a constituent, also significantly reduced serum triglycerides in animal studies. No human RCT on T. bellirica for triglycerides alone has been published.
T. bellirica extracts demonstrate in vitro wound healing properties (ethanolic extract) and antimicrobial activity against wound-associated pathogens. Classical Ayurvedic texts describe application of fruit paste to chronic wounds, ulcers, cuts, and bruises. ScienceDirect documents that ethanolic extract demonstrates in vitro wound healing properties. The astringent tannins additionally support tissue repair by promoting hemostasis and reducing bacterial contamination.
Belleric myrobalan has broad traditional use for abdominal complaints including bloating, gas, cramping, dyspepsia, and indigestion across Ayurveda, Unani, and traditional Chinese medicine. Mechanistic studies confirm antispasmodic properties via anticholinergic and calcium antagonist effects. Its role in Triphala as a digestive tonic is the most prominently documented traditional application.
Classical Ayurvedic combinations containing T. bellirica have been used for rheumatic diseases and arthritis. Traditional texts document seed oil of T. bellirica in rheumatism. The in vitro anti-inflammatory evidence (TNF-α suppression, LOX-1 inhibition, lipoxygenase inhibition) provides mechanistic support. Traditional use across Ayurveda, Unani, and traditional Chinese medicine for rheumatism is well-documented.
In Ayurvedic practice, belleric myrobalan fruit powder has traditionally been used as a tooth powder to reduce gum pain and bad breath. This use is documented in classical texts and ethnobotanical records but lacks dedicated clinical trial evidence. The antimicrobial activity of its tannins and gallic acid against oral pathogens provides a plausible mechanistic rationale.
Antihypertensive activity of T. bellirica is documented in traditional Indian medicine and ScienceDirect notes it is used for hypertension. Animal and in vitro studies support vasodilatory and antihypertensive effects, and a polyherbal formulation containing T. bellirica showed blood pressure-lowering effects in a rat hypertension model. No dedicated human RCT on T. bellirica monotherapy for blood pressure has been published.
Belleric myrobalan is consistently cited for bronchitis across Ayurvedic, Unani, Siddha, and traditional Chinese medicine systems. The Chinese Pharmacopeia specifically lists T. bellirica for treating bronchitis. Its bronchodilatory, antispasmodic, and antimicrobial properties provide mechanistic support. Traditional use for bronchial conditions is among the most consistently documented applications of this herb.
Ayurvedic and Unani traditions extensively document the use of belleric myrobalan fruit for cough, cold, and throat-related conditions. Classical texts describe combinations of T. bellirica powder with salt, long pepper, and honey for cough and cold relief. Its antimicrobial activity against respiratory pathogens provides some mechanistic support, but no dedicated human clinical trials for cold or flu have been conducted.
Belleric myrobalan is one of the most prominently documented Ayurvedic remedies for constipation, referenced across multiple classical texts including the Charaka Samhita. Half-ripe fruit is used as a purgative and dried fruit powder as a laxative and bowel tonic. The fixed oil of the seed is purgative in large doses. Its role in Triphala—a widely used Ayurvedic laxative compound—further reinforces this traditional association.
Belleric myrobalan is classified as an antipyretic in multiple traditional medical systems including Ayurveda, Unani, and Siddha. Classical Ayurvedic texts reference its use for Jvara (fever). The fruit is listed among its documented traditional actions as antipyretic in pharmacological literature reviews. No clinical human trials on T. bellirica for fever are available.
Belleric myrobalan has deep traditional roots as an ocular remedy in Ayurveda. Classical Ayurvedic formulations including Triphala Ghrita (containing T. bellirica) have been used for myopia, hypermetropia, and other eye disorders. Topical application of fruit paste or lotion to the eye region is recorded in classical texts, and seed oil is described as beneficial for eye disorders. RxList and Ayurvedic pharmacopeia sources document its use as a lotion for sore eyes.
Traditional Ayurvedic texts describe the use of belleric myrobalan fruit powder as a tooth powder for gum pain. The antimicrobial activity of its polyphenols against oral pathogens provides mechanistic support. Triphala (containing T. bellirica) is documented as a traditional mouthwash and gargle. No human RCT specifically for periodontal health using T. bellirica monotherapy has been published.
Belleric myrobalan is classified as a rasayana (rejuvenative) herb in Ayurveda, one of the most exalted traditional categories indicating anti-aging and longevity-promoting properties. It is described in the Charaka Samhita as bestowing longevity, strength, and intellectual power. Its antioxidant polyphenols may mechanistically support healthy aging at the cellular level, but no direct human aging trials exist.
Belleric myrobalan fruit pulp is documented in Ayurvedic texts and ethnobotanical records as a traditional remedy for piles (hemorrhoids). The astringent action of tannins is thought to reduce venous engorgement and inflammation of hemorrhoidal tissue. References appear consistently across Ayurveda, Unani, and traditional medicine sources from South Asia.
Belleric myrobalan is a core traditional remedy for excess mucus and phlegm in Ayurveda, specifically classified as beneficial for Kapha-type conditions associated with mucus accumulation. Gaia Herbs documents its alterative properties promoting normal secretions in the lungs. Classical texts and ethnobotanical records across South and Southeast Asia describe it for hoarseness of voice, cough with phlegm, and bronchial congestion.
Belleric myrobalan is classified as an anthelmintic in Ayurvedic, Unani, and Siddha medical systems, with use for intestinal worms documented across classical texts and ethnobotanical surveys from South Asia. Traditional combinations with butea seeds for antiparasitic use are referenced. Pharmacologically, the triterpenoid and polyphenol content provides mechanistic plausibility, though controlled human antiparasitic trials have not been identified.
Belleric myrobalan is documented in Ayurvedic and Unani texts as a remedy for sore throat, hoarseness, and tonsillitis. RxList and Ayurvedic sources confirm its use for respiratory tract infections including sore throat. Its antimicrobial activity against Streptococcus pneumoniae and Staphylococcus aureus in vitro provides mechanistic support, though clinical trials on sore throat specifically are lacking.
Anti-ulcer and anti-ulcerogenic activity is documented for T. bellirica in multiple pharmacological reviews. Traditional Ayurvedic and Unani texts describe its use for gastric ulcers. Literature documents inhibition of H. pylori, the primary ulcer-causing pathogen. The ScienceDirect comprehensive review (2020) specifically catalogs anti-ulcerogenic activity among established pharmacological properties.
Volver